EHTH - eHealth, Inc.
NASDAQ
->
Financial Services
->
Insurance Brokers
Santa Clara,
United States
Type: Equity
EHTH price evolution
EHTH
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $118.81 | $155.21 | $156.42 | $183.87 |
| Short term investments | $5.93 | $8.47 | $36.62 | $22.06 |
| Net receivables | $922.17 | $781.1 | $790.23 | $803.06 |
| Inventory | ||||
| Total current assets | $382.35 | $396.74 | $390.23 | $420.66 |
| Long term investments | ||||
| Property, plant & equipment | $27.63 | $29.37 | $28.97 | $30.38 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $730.99 | $629.63 | $663.21 | $662.37 |
| Total investments | $5.93 | $8.47 | $36.62 | $22.06 |
| Total assets | $1113.35 | $1026.38 | $1053.43 | $1083.03 |
| Current liabilities | ||||
| Accounts payable | $7.2 | $7 | $6.39 | $5.27 |
| Deferred revenue | ||||
| Short long term debt | $7.07 | $6.9 | $6.5 | $6.63 |
| Total current liabilities | $78.54 | $53.25 | $44.74 | $51.47 |
| Long term debt | $96.09 | $97.46 | $97.81 | $99.06 |
| Total noncurrent liabilities | $130.72 | $124.61 | $127.79 | $132.21 |
| Total debt | $103.16 | $104.36 | $104.31 | $105.69 |
| Total liabilities | $209.26 | $177.86 | $172.53 | $183.67 |
| Shareholders' equity | ||||
| Retained earnings | $7.28 | -$34.41 | $12.84 | $45.75 |
| Other shareholder equity | -$0.08 | -$0.13 | -$0.19 | $0.05 |
| Total shareholder equity | $606.03 | $559.64 | $600.91 | $627.91 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $118.81 | $17.78 | $85.17 | $47.11 |
| Short term investments | $5.93 | $41.31 | $49.62 | |
| Net receivables | $922.17 | $245.38 | $914.01 | $794.2 |
| Inventory | ||||
| Total current assets | $382.35 | $401.08 | $407.59 | $330.99 |
| Long term investments | ||||
| Property, plant & equipment | $27.63 | $32.02 | $49.48 | $57.17 |
| Goodwill & intangible assets | $1.92 | $48.8 | ||
| Total noncurrent assets | $730.99 | $711.53 | $741.71 | $709.03 |
| Total investments | $5.93 | $41.31 | $49.62 | |
| Total assets | $1113.35 | $1112.61 | $1149.29 | $1040.02 |
| Current liabilities | ||||
| Accounts payable | $7.2 | $6.73 | $13.75 | $36.92 |
| Deferred revenue | $0.31 | |||
| Short long term debt | $7.07 | $6.49 | $5.54 | $5.19 |
| Total current liabilities | $78.54 | $60.56 | $75.47 | $84.41 |
| Long term debt | $96.09 | $66.13 | $35.83 | $41.37 |
| Total noncurrent liabilities | $130.72 | $137.81 | $91.72 | $118.06 |
| Total debt | $103.16 | $106.8 | $41.37 | $46.56 |
| Total liabilities | $209.26 | $198.37 | $167.18 | $202.46 |
| Shareholders' equity | ||||
| Retained earnings | $7.28 | $73.8 | $193.21 | $316.15 |
| Other shareholder equity | -$0.08 | -$0.07 | $0.39 | $0.35 |
| Total shareholder equity | $606.03 | $650.96 | $749.52 | $837.56 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $247.66 | $64.72 | $66.77 | $73.72 |
| Cost of revenue | $1.11 | $0.19 | $0.25 | $0.21 |
| Gross Profit | $246.55 | $64.52 | $66.52 | $73.51 |
| Operating activities | ||||
| Research & development | $17.16 | $13.83 | $14.5 | $15.54 |
| Selling, general & administrative | $111.47 | $49.41 | $45.3 | $53.9 |
| Total operating expenses | $187.19 | $103.92 | $92.67 | $96.4 |
| Operating income | $59.37 | -$39.4 | -$26.15 | -$22.89 |
| Income from continuing operations | ||||
| EBIT | $69.44 | -$39.53 | -$26.04 | -$23.49 |
| Income tax expense | $6.28 | -$2.51 | -$2.54 | -$3.61 |
| Interest expense | $10.97 | |||
| Net income | ||||
| Net income | $52.19 | -$37.02 | -$23.5 | -$19.88 |
| Income (for common shares) | $41.69 | -$47.24 | -$32.91 | -$28.05 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $452.87 | $405.36 | $538.2 | $582.77 |
| Cost of revenue | $1.77 | $1.65 | $1.99 | $4.08 |
| Gross Profit | $451.1 | $403.71 | $536.21 | $578.69 |
| Operating activities | ||||
| Research & development | $61.03 | $78.81 | $83.8 | $65.19 |
| Selling, general & administrative | $260.09 | $266.9 | $347 | $285.79 |
| Total operating expenses | $480.17 | $506.42 | $661.85 | $525.37 |
| Operating income | -$29.07 | -$102.71 | -$125.64 | $53.32 |
| Income from continuing operations | ||||
| EBIT | -$19.62 | -$106.39 | -$124.89 | $53.99 |
| Income tax expense | -$2.38 | -$17.67 | -$20.52 | $8.54 |
| Interest expense | $10.97 | |||
| Net income | ||||
| Net income | -$28.21 | -$88.72 | -$104.38 | $45.45 |
| Income (for common shares) | -$66.52 | -$119.41 | -$122.94 | $45.45 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $52.19 | -$37.02 | -$23.5 | -$19.88 |
| Operating activities | ||||
| Depreciation | $4.78 | $4.75 | $0.64 | $0.66 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.47 | $6.55 | $6.19 | $4.99 |
| Total cash flows from operations | -$33.39 | -$24.68 | -$9.43 | $60.8 |
| Investing activities | ||||
| Capital expenditures | -$1.99 | -$4.21 | -$2.34 | -$2.23 |
| Investments | $2.59 | $28.5 | -$14.19 | -$22.01 |
| Total cash flows from investing | $0.6 | $24.29 | -$16.54 | -$24.24 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.98 | -$0.88 | -$0.36 | -$0.43 |
| Net borrowings | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Total cash flows from financing | -$3.65 | -$0.89 | -$1.25 | -$0.44 |
| Effect of exchange rate | $0.04 | $0.07 | -$0.23 | $0.11 |
| Change in cash and equivalents | -$36.4 | -$1.22 | -$27.45 | $36.23 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$28.21 | -$88.72 | -$104.38 | $45.45 |
| Operating activities | ||||
| Depreciation | $19.92 | $3.85 | $5.97 | $5.19 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $23.21 | $20.32 | $32.86 | $25.17 |
| Total cash flows from operations | -$6.69 | -$26.87 | -$162.62 | -$107.86 |
| Investing activities | ||||
| Capital expenditures | -$10.78 | -$15.51 | -$20.86 | -$23.76 |
| Investments | -$5.11 | $41.37 | $8.23 | -$49.53 |
| Total cash flows from investing | -$15.89 | $25.86 | -$12.63 | -$73.28 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$2.65 | -$0.89 | -$0.63 | $210.16 |
| Net borrowings | -$0.04 | $64.73 | -$0.15 | -$0.16 |
| Total cash flows from financing | -$6.22 | $63.84 | $213.24 | $201.25 |
| Effect of exchange rate | -$0.02 | -$0.35 | $0.06 | $0.19 |
| Change in cash and equivalents | -$28.83 | $62.48 | $38.05 | $20.29 |
News
Fundamentals
| Market cap | $128.54M |
|---|---|
| Enterprise value | $112.89M |
| Shares outstanding | 28.63M |
| Revenue | $452.87M |
|---|---|
| EBITDA | -$8.81M |
| EBIT | -$19.62M |
| Net Income | -$28.21M |
| Revenue Q/Q | 26.15% |
| Revenue Y/Y | 11.72% |
| P/E ratio | -4.56 |
|---|---|
| EV/Sales | 0.25 |
| EV/EBITDA | -12.82 |
| EV/EBIT | -5.75 |
| P/S ratio | 0.28 |
| P/B ratio | 0.21 |
| Book/Share | 21.17 |
| Cash/Share | 4.15 |
| EPS | -$0.99 |
|---|---|
| ROA | -2.64% |
| ROE | -4.71% |
| Debt/Equity | 0.35 |
|---|---|
| Net debt/EBITDA | -10.27 |
| Current ratio | 4.87 |
| Quick ratio | 4.87 |